Home > Healthcare > Medical Devices > Therapeutic Devices > Membrane Oxygenators Market

Membrane Oxygenators Market Size

  • Report ID: GMI12827
  • Published Date: Dec 2024
  • Report Format: PDF

Membrane Oxygenators Market Size

The global membrane oxygenators market, valued at USD 132.1 million in 2024, is projected to grow at a CAGR of 2.2% from 2025 to 2034. The increasing prevalence of respiratory and cardiac disorders, including conditions like ARDS, cardiogenic shock, and myocarditis, drives the demand for advanced oxygenation systems, with membrane oxygenators being essential. Additionally, the growing geriatric population, more susceptible to these conditions, further boosts market growth. Technological advancements, such as hollow fiber membranes that improve gas exchange efficiency, also contribute to their expanding adoption in clinical settings.

 

 

Another driver is the growing utilization of extracorporeal membrane oxygenation (ECMO) therapy in critical care, particularly during emergencies like acute myocardial infarctions or post-transplant complications. The COVID-19 pandemic also highlighted the importance of membrane oxygenators in managing severe respiratory failure cases, significantly boosting market awareness and adoption.
 

Increased healthcare spending in developing nations, coupled with the expansion of advanced healthcare infrastructure, has further propelled market growth. Government initiatives to improve healthcare access and increasing training for ECMO deployment are also encouraging the use of membrane oxygenators.
 

Moreover, the development of portable and user-friendly systems is expanding the application of these devices in neonatal and pediatric care. With these innovations and an emphasis on improving patient outcomes, the membrane oxygenators industry is poised for substantial growth over the coming years.
 

Membrane oxygenators are medical devices used in extracorporeal life support to facilitate gas exchange by removing carbon dioxide and delivering oxygen to the blood. Utilizing advanced membrane technologies like hollow fibers or flat sheets, they are essential in managing respiratory and cardiac failures, especially during ECMO procedures and critical care interventions.  

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for membrane oxygenators was valued at USD 132.1 million in 2024 and is projected to reach USD 162.8 million by 2034, driven by a CAGR of 2.2% during the forecast period, primarily due to the rising prevalence of respiratory and cardiac disorders.

Hollow fiber membrane oxygenators are expected to account for a significant market share, growing at a CAGR of 2.6% to surpass USD 100.6 million by 2034, driven by their superior efficiency and widespread use in critical care applications.

The U.S. market was valued at USD 44.2 million in 2024 and is anticipated to grow at a CAGR of 1.4% from 2025 to 2034, driven by the increasing prevalence of chronic

Key players in the industry include Abbott, BRAILE, Chalice, CytoSorbents, EUROSETS, Fresenius, GETINGE, LivaNova, Medtronic, MicroPort, NIPRO, and PrecisionMedical.

Membrane Oxygenators Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 15
  • Tables & Figures: 134
  • Countries covered: 19
  • Pages: 140
 Download Free Sample